simvastatin has been researched along with Cancer of Head in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badiee, P; Berbeco, RI; Cheah, E; Dehghankelishadi, P; Dmochowska, N; Kempson, I; Maritz, MF; Thierry, B | 1 |
| Buchwald, ZS; Burnham, AJ; Kansal, V; Kinney, BLC; Lesinski, GB; Paulos, C; Saba, NF; Schmitt, NC | 1 |
| Kou, Y; Li, M; Liu, B; Liu, H; Rong, X; Wang, C; Yang, P; Zhang, Y; Zhou, Q | 1 |
| Gehrke, T; Hackenberg, S; Hagen, R; Ickrath, P; Kleinsasser, N; Schendzielorz, P; Scherzad, A | 1 |
| Aigner, A; Boehm, A; Dietz, A; Mozet, C; Stoehr, M; Wichmann, G | 1 |
| Kakehata, S; Maruya, S; Mizukami, H; Myers, JN; Shinkawa, H; Shirasaki, T; Takahata, T; Takeda, I; Yagihashi, S | 1 |
6 other study(ies) available for simvastatin and Cancer of Head
| Article | Year |
|---|---|
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.
Topics: Animals; Cholesterol, HDL; Head and Neck Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Mice; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2022 |
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.
Topics: Animals; Head and Neck Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Checkpoint Inhibitors; Lovastatin; Mice; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |
Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
Topics: Animals; Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Kruppel-Like Transcription Factors; Mice; Mouth Neoplasms; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Interleukin-8; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2017 |
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Topics: Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Head and Neck Neoplasms; Humans; KB Cells; Male; Neoplasm Staging; Risk Factors; Simvastatin; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2014 |
Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells.
Topics: Anticholesteremic Agents; Carcinoma, Squamous Cell; Caspase 3; Cell Proliferation; Cell Survival; Focal Adhesion Kinase 1; G1 Phase; Head and Neck Neoplasms; Humans; Integrin beta1; Mevalonic Acid; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Simvastatin; Tumor Cells, Cultured | 2007 |